developing a multi-criteria approach for drug reimbursement decision making: an initial step forward...
Post on 19-Dec-2015
216 Views
Preview:
TRANSCRIPT
Developing a multi-criteria approach for drugreimbursement decision making: an initial step
forward
Francois Dionne- Centre for Clinical Epidemiology and Evaluation
Farzad Ali- Pfizer
Plan
1. Why this initial step2. How was the work done3. Where do we stand now4. What’s next
Why this initial step
Industry is evolvingPAST
Regulatory Need
PRESENT
Regulatory Need
Payer Need
What could HTA/Payers consider?
Cost-Effectiveness
Safety
Efficacy(Comparator, endpoint)
Patient PreferenceEthical and equity
considerationBudget Impact &
AffordabilityUnmet need
$ Burden of Disease
Reward future innovation (dynamic
efficiency)
Severity
Price
How was the work done
• Two workshops- November 2013, April 2014• Key stakeholders involved• Report is a summary of the discussions
Where do we stand now
• Overarching context• Seven guiding principles• Ten criteria
Dionne F, Mitton C, Dempster B, Lynd LD. Developing a multi-criteria approach for drug reimbursement decision making: an initial step forward. J Popul Ther Clin Pharmacol. 2015;22(1):e68-77. Epub 2015 Feb 12.
What’s next
The next steps involve:• Finalization of the criteria selection • Refinement of the criteria definitions to ensure
clarity and minimize potential overlap between criteria
• Criteria weights have to be set, and each criterion needs a rating scale
• Finally, the completed framework should be tested for validity with some past submissions to examine the robustness of the entire rating tool
top related